Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis

Novartis Pharmaceuticals · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
lupus nephritis, systemic lupus erythematosus (sle), lupus nephritis (ln), secukinumab, renal biopsy, estimated glomerular filtration rate (egfr), urine protein-to-creatinine ratio (upcr), standard of care (soc) background therapy, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 918011
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.